乌鸦传媒

Compounders only have 2 to 3 months left to copy injectable

News and commentary from the endocrinology world

Cost, insurance coverage likely play outsized role

Also in TTHealthWatch: depression treatment after positive screening in primary care

Why it's unlikely to help most people

Social support may be key to improving glycemic control, experts say

Experts weigh in on weight regain, cardiometabolic fallout, and the future of tailored care

20% lower risk of VTE observed in large retrospective study of diabetes patients

Existing models improved only slightly after accounting for certain female risk factors

Agency has failed to hold food manufacturers accountable, said Sen. Bernie Sanders

But the drug didn't appear to lower the risk of incident nonproliferative diabetic retinopathy

Experts tackle myths, data bias, and game-changing outcomes of obesity drugs

Eating more dark chocolate was associated with a lower risk of type 2 diabetes

Dual GLP-1/GIP drug yielded an average 47% greater relative weight loss compared to semaglutide